Clinical Trial Update: CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation [NA]

View source ↗

Summary

This clinical trial update reports on a study evaluating CD8+ T cell depletion as prophylaxis against graft-versus-host disease after peripheral blood stem cell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Hodgkin Lymphoma
• Multiple Myeloma
• Non-hodgkin Lymphoma

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Hematologic Malignancy, AML | NA | Status: COMPLETED